HomeNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Previous close
$1.09
Day range
$1.06 - $1.20
Year range
$0.46 - $4.44
Market cap
151.21M USD
Avg Volume
131.02K
P/E ratio
2.23
Dividend yield
-
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 521.00K | -78.66% |
Operating expense | 1.21M | -28.89% |
Net income | -1.29M | -6.68% |
Net profit margin | -248.18 | — |
Earnings per share | — | — |
EBITDA | -1.17M | 31.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.31M | 197.55% |
Total assets | 3.49M | -10.06% |
Total liabilities | 1.85M | -33.94% |
Total equity | 1.63M | — |
Shares outstanding | 126.01M | — |
Price to book | -2.42 | — |
Return on assets | -56.21% | — |
Return on capital | -74.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.29M | -6.68% |
Cash from operations | -1.80M | 12.71% |
Cash from investing | — | — |
Cash from financing | -1.32M | -163.17% |
Net change in cash | -3.12M | -12,096.15% |
Free cash flow | -1.22M | 35.34% |
About
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Founded
2000
Headquarters
Website
Employees
14
